Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
Slowing of Peripheral Artery Disease: Another Liraglutide Benefit? GLP-1 receptor agonist significantly slowed progression over 6 months Mar 13, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Wegovy Approved for Major Heart Disease Prevention New indication for patients with obesity or overweight and a history of cardiovascular disease Mar 08, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol? Case study highlights importance of proper urine sample storage Feb 07, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Subclasses of Steatotic Liver Disease Can Help Determine Prognosis Risk of liver decompensation increased progressively when alcohol intake came into play Jan 18, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes News and commentary from the endocrinology world Jan 02, 2024
Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth News and commentary from the endocrinology world Dec 26, 2023
Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry News and commentary from the endocrinology world Dec 19, 2023
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves News and commentary from the endocrinology world Dec 12, 2023
USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesity Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D News and commentary from the endocrinology world Dec 04, 2023
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis News and commentary from the endocrinology world Nov 27, 2023
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd News and commentary from the endocrinology world Nov 21, 2023
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? News and commentary from the endocrinology world Nov 07, 2023
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer News and commentary from the endocrinology world Oct 31, 2023
Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? News and commentary from the endocrinology world Oct 24, 2023
Certain Factors Predict Weight Regain After Big Losses But even "regainers" still kept off most of the weight Oct 17, 2023
Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortality Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risks Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test News and commentary from the endocrinology world Oct 10, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
Over One-Third of Adults in 22 States Have Obesity, CDC Says No states hit this threshold a decade ago Sep 22, 2023
